Ciprofloxacin-induced cholestatic jaundice.
Thakur
Bhagwan S
BS
Jain
Ajay K
AK
Sirkar
Shohini
S
Joshi
Gunjan
G
Joshi
Rachana
R
D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects*; D017332:Cetirizine / Q000627:therapeutic use; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000009:adverse effects*; D005938:Glucocorticoids / Q000627:therapeutic use; D039563:Histamine H1 Antagonists, Non-Sedating / Q000627:therapeutic use; D006801:Humans; D041781:Jaundice, Obstructive / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D000890:Anti-Infective Agents; D002756:Cholagogues and Choleretics; D005938:Glucocorticoids; D039563:Histamine H1 Antagonists, Non-Sedating; D002939:Ciprofloxacin; D014580:Ursodeoxycholic Acid; D011239:Prednisolone; D017332:Cetirizine